Stone House Investment Management »

Qualigen Therapeutics shares owned by Stone House Investment Management

Quarter-by-quarter ownership of Qualigen Therapeutics (QLGN) shares owned by Stone House Investment Management from 13F filings

Historical chart of Stone House Investment Management investment in Qualigen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Qualigen Therapeutics held by Stone House Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Qualigen Therapeutics by Stone House Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1k 200 5.72

More positions owned by Stone House Investment Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core Total Usd (IUSB)
Ishares Tr Core S&p500 Etf (IVV)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Procter & Gamble Company (PG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr S&p 100 Etf (OEF)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core Msci Total (IXUS)
Ishares Tr 10-20 Yr Trs Etf (TLH)
Blackrock Etf Trust Ishares Us Thema (THRO)
Blackrock Etf Trust Ishares A I Inno (BAI)

View all positions for Stone House Investment Management

Top funds holding Qualigen Therapeutics

Cubist Systematic Strategies
UBS Group
BlackRock
Tower Research Capital
Harbour Investments
Stone House Investment Management
HighMark Wealth Management
Group One Trading
Us Bancorp
UMA Financial Services
SBI Securities
Danske Bank A/s

View all funds holding Qualigen Therapeutics